Byteflies
- Company typePrivate
- Founded2014
- HeadquartersAntwerp, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
Byteflies firmographics
Firmographics- Name
- Byteflies
- Legal name
- Byteflies NV
- Website
- https://byteflies.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Byteflies industry classification
Industry- Product category
- Remote Patient Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics) (HLACAPAL), Neurology Telemedicine Platforms (HLALAGAC)
Keywords
Where Byteflies is headquartered
LocationHeadquarters
- HQ city
- Antwerp
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Byteflies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Remote Patient Monitoring - Pay-per-Use: Pay-per-use model where healthcare providers pay per patient monitored. No prior investment required. Covers device usage, data transmission, and basic reporting.
- Data Annotation Services: Optional AI-powered and human-driven annotation services for ECG and EEG data analysis. Additional fee for detailed diagnostic insights and arrhythmia detection.
- Clinical Trial Telemetry Services: Precision-driven data collection for clinical trials and real-world evidence studies. Serves life sciences and MedTech companies with compliant, high-quality patient vital signs data collection.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Pay-per-use monitoring - per patient basis |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Byteflies product offering
Product offeringCore offering
Byteflies provides medically-certified wearable telemonitoring solutions built around the Sensor Dot, a multi-purpose prescription medical device that captures biopotential (EEG, ECG, EMG) and motion data. The company delivers a suite of condition-specific monitoring "Flows" for cardiology, neurology/epilepsy, oncology, and COVID-19, bundled with AI analytics, human annotation services, device logistics, and EHR integration on a pay-per-use model. The platform enables healthcare providers and life sciences companies to obtain continuous, high-quality vital signs data from patients' homes without capital investment.
Product overview
Byteflies offers a modular telemonitoring platform built around the Sensor Dot wearable device and a suite of specialized monitoring Flows. The core architecture consists of medical-grade wearable hardware (Sensor Dot with disposable adhesive patches) combined with software platforms (Clinician Dashboard, optional data annotation services) and logistics management. The product portfolio is organized by therapeutic domain: Cardiology Flows (ECG Flow, 24h Flow, 24h Flow Non-Linear, Afib Flow, Plus Flow, Heart Failure Flow), Neurology/Epilepsy (EEG Flow, EpiCare@Home), and specialized applications (Covid Flow, Onco Flow). All flows operate on a pay-per-use model with end-to-end support including device logistics, stock management, and maintenance. The platform is medically certified (CE marked MDR, FDA 510(k) cleared, ISO 13485 compliant) and integrates with hospital EHR systems.
Differentiator
Problem solved
Functional benefit
Brands
- CardioCare@Home: Cardiac telemonitoring solution providing ECG monitoring, 24h monitoring, Afib monitoring, and heart failure monitoring for patients at home.
- Covid Flow
- EpiCare@Home
- Care@Home
- Sensor Dot
- Onco Flow
Products and services
- Sensor Dot Multi-purpose prescription wearable medical device that records biopotential (EEG, ECG, EMG) and inertial measurement unit (IMU) data. Cleared in EU (CE) and US (FDA 510(k)). Configurable with disposable adhesive patches for extended home monitoring.
- ECG Flow ECG-as-a-service offering precise raw 3-lead ECG data via the Sensor Dot while ensuring patient comfort during daily activities. Provides continuous cardiac rhythm recording with an easily exchangeable and rechargeable patch for extended monitoring with minimal lifestyle disruption.
- 24h Flow Hassle-free alternative to 24-hour Holter monitoring. Patients receive an accurate, comfortable multi-lead ECG patch with a pre-paid return envelope. After 24 hours, data is processed by AI and trained annotators, with high-quality insights delivered to the clinician dashboard.
- 24h Flow Non-Linear Advanced 24-hour ECG monitoring solution with enhanced lead placement using a triangular electrode configuration. Designed for more complex cases, offering comprehensive data and deeper diagnostic insights with higher P-wave clarity and improved diagnostic confidence.
- Afib Flow Continuous cardiac monitoring focused on atrial fibrillation detection and post-stroke/TIA care. Offers detailed annotations during critical post-insult days with prompt and precise care delivery when every moment counts.
- Plus Flow Enhanced ECG patch solution with comprehensive ECG annotation support for a wide range of arrhythmias. Adaptable for up to two weeks of monitoring with in-depth ECG analysis, minimal setup, and higher diagnostic yield for capturing significant cardiac events.
- Heart Failure Flow Customizable flow providing vital insights for heart failure patients including blood pressure, heart rate, body weight, body temperature, and activity. Enables rapid response, shorter hospital stays, and improved patient recovery.
- EEG Flow EEG-as-a-service for neurology applications, enabling insights in seizure burden or sleep quality from the patient's home. Collects raw EEG data that can be combined with ECG and motion data in a multimodal setup for improved sensitivity.
- EpiCare@Home Epilepsy monitoring solution combining medical wearable devices for low-montage EEG recording augmented with cardiorespiratory and motion data. Enables multi-day to multi-week seizure monitoring at home with human annotation services and clinical dashboard review.
- Covid Flow Home monitoring solution for COVID-19 patients including BioMeTs, patient app, healthcare provider dashboard, and telemonitoring team. Features NEWS2-based vital sign trending and integrates with hospital EMR systems for early deterioration detection.
- Onco Flow Cardio-oncology monitoring solution addressing cardiotoxicity risks from cancer treatments. Provides continuous remote monitoring features relevant during and after cancer treatment, including for new classes of immunotherapies.
- Data Annotation Services Human-driven annotation service where trained annotators review wearable device data and annotate potential seizure events shared with neurologists for final validation. Generates high-quality labeled data for algorithm development while enabling clinical use without increasing physician data review burden.
- 5G-CARE Telemonitoring solution with 5G connectivity and real-time data processing developed in partnership with Citymesh. Enables patients to be better monitored at home or on the go with improved connectivity.
Quantifiable outcome
- 3-4x faster cardiac monitoring process compared to traditional Holter, with comparable data quality and 93% patient positive clinical impact
- +4 more outcomes
Companies that use Byteflies
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles3 records
Byteflies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability9 records
Feature5 records
Byteflies partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- CitymeshcoreStrategic partnership for 5G-CARE project enabling telemonitoring with 5G connectivity. Patients can be better monitored at home or on the go with real-time data processing.
- nexuzhealthcoreOncoCare@home project collaboration integrating telemetry with electronic patient records. Demonstrated significant benefits during COVID-19 pandemic.
- UCB PharmacoreDigital health collaboration for epilepsy care innovation. UCB recognized value of EpiCare@Home and similar solutions for clinical trials and patient care.
- Epilepsy FoundationcorePartner organization for epilepsy awareness and advocacy. Hosts AEDD and Pipeline conferences bringing together technology enablers for epilepsy care.
- Thomas Jefferson UniversitycoreOngoing prospective clinical trial (NCT05738226) at TJU focusing specifically on focal epilepsies using EpiCare@Home technology.
- Plug 'n Patch ConsortiumcoreResearch consortium including academic and industrial partners awarded grant in 2019 to develop EEG patch designs with embedded biopotential electrodes.
- EIT Health (SeizeIT studies)coreEU-funded research initiative supporting SeizeIT1 and SeizeIT2 studies for seizure detection algorithm development and clinical validation.
- Multiple Academic Medical CenterscoreLong-standing collaborations with academic partners in EU and UK for data collection and algorithm validation across 600+ patients with 4,000+ seizures captured.
- Dr. Léopold LoumayeminorCardiologist at private practice who successfully integrated Byteflies telemonitoring solution into clinical workflow and serves as key opinion leader.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Byteflies competitors and assessment
Company assessmentDirect peers
- NeuroPace: NeuroPace's RNS System is a neurostimulation device for epilepsy that, like Byteflies' EpiCare@Home, addresses clinical decision-making for refractory epilepsy patients using chronic neural monitoring data.
- AliveCor: AliveCor's KardiaMobile and KardiaBand provide consumer- and clinician-facing single-lead ECG capture with AI-driven arrhythmia detection, competing with Byteflies' ECG Flow in cardiology and arrhythmia screening use cases.
- Empatica: Empatica's EpiMonitor and Embrace are FDA-cleared wearable devices for seizure detection and continuous multimodal monitoring, directly comparable to Byteflies' EpiCare@Home epilepsy monitoring solution.
- Compumedics: Compumedics manufactures EEG, sleep, and long-term monitoring systems with cloud and ambulatory capabilities, overlapping with Byteflies' EEG Flow and EpiCare@Home neurology offerings.
- iRhythm Technologies: iRhythm's Zio patch is a direct competitor to Byteflies' ECG/24h Flow products, providing ambulatory cardiac monitoring with proprietary AI arrhythmia detection and a similar pay-per-use service model targeting hospitals and clinicians.
- Current Health (Best Buy Health): Current Health provides a remote patient monitoring platform with wearable biosensors, vital-sign capture, and EHR integration — directly comparable to Byteflies' continuous vitals monitoring across multiple therapeutic areas.
- Preventice Solutions (Boston Scientific): BodyGuardian remote cardiac monitoring solutions target the same ambulatory cardiology market as Byteflies' CardioCare@Home, including Holter, event, and mobile cardiac telemetry services for hospitals.
- Huma Therapeutics: Huma provides a remote patient monitoring platform for hospitals, combining wearable vitals capture with clinician dashboards — comparable to Byteflies' software-platform layer spanning cardiology, oncology, and general monitoring.
Broad incumbents
- Medtronic: Medtronic's LINQ insertable cardiac monitor and broader diagnostics portfolio compete with Byteflies in cardiac ambulatory monitoring and remote patient monitoring for cardiology departments.
- BioTel (Philips): Philips BioTel Heart provides ambulatory cardiac monitoring services (MCOT) comparable to Byteflies' ECG/24h Flow, embedded within a much larger portfolio of connected hospital technologies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Byteflies social profiles
Digital presenceByteflies compliance and trust
Trust signalCompliance6 records
Byteflies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Byteflies leadership team
Management profileNumber of profiles
Profiles5 records
Byteflies funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Byteflies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Byteflies
What does Byteflies do?
Byteflies provides medically-certified wearable telemonitoring solutions built around the Sensor Dot, a multi-purpose prescription medical device that captures biopotential (EEG, ECG, EMG) and motion data. The company delivers a suite of condition-specific monitoring "Flows" for cardiology, neurology/epilepsy, oncology, and COVID-19, bundled with AI analytics, human annotation services, device logistics, and EHR integration on a pay-per-use model. The platform enables healthcare providers and life sciences companies to obtain continuous, high-quality vital signs data from patients' homes without capital investment.
Is Byteflies a public or private company?
Byteflies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Byteflies founded?
Byteflies was founded in 2014. It employs 11 to 50 people.
Where is Byteflies based?
Byteflies is headquartered in Antwerp, Belgium, in the Europe region.
How does Byteflies make money?
Three revenue lines are on record. Remote Patient Monitoring - Pay-per-Use is the primary driver. The others are data Annotation Services and clinical Trial Telemetry Services.
Who are Byteflies's main competitors?
Direct peers on record are NeuroPace, AliveCor, Empatica, Compumedics, iRhythm Technologies, Current Health (Best Buy Health), Preventice Solutions (Boston Scientific) and Huma Therapeutics. Broad incumbents are Medtronic and BioTel (Philips).
Does Byteflies have an API?
No public API is recorded for Byteflies.
What industry is Byteflies in?
Byteflies's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.